Abstract
Management of pain and anxiety for children requiring urgent care has progressed dramatically in the past decade. However, the administration of analgesia and sedation in children is inconsistent, with significant practice variation among practitioners, and especially amid younger children who receive less than optimal analgesia. Nasal administrations of drugs have several significant advantages over current practices. The nose has a very rich vascular supply, it facilitates direct absorption to the systemic blood supply and increases bioavailability of the drug, compared to oral administration. The current review summarizes available information on the use of intranasal drug delivery for children in acute illness. Midazolam (Versed), Fentanyl, Diamorphine and Ketamine are discussed, as well as pitfalls and caveats of intranasal drug use.
Keywords: bioavailability, nasal cavity, Drug delivery, controlled trails, Benzodiazepins, Intranasal fentanyl
Current Drug Therapy
Title: Intranasal Drug Delivery for Children with Acute Illness
Volume: 1 Issue: 1
Author(s): Ran D. Goldman
Affiliation:
Keywords: bioavailability, nasal cavity, Drug delivery, controlled trails, Benzodiazepins, Intranasal fentanyl
Abstract: Management of pain and anxiety for children requiring urgent care has progressed dramatically in the past decade. However, the administration of analgesia and sedation in children is inconsistent, with significant practice variation among practitioners, and especially amid younger children who receive less than optimal analgesia. Nasal administrations of drugs have several significant advantages over current practices. The nose has a very rich vascular supply, it facilitates direct absorption to the systemic blood supply and increases bioavailability of the drug, compared to oral administration. The current review summarizes available information on the use of intranasal drug delivery for children in acute illness. Midazolam (Versed), Fentanyl, Diamorphine and Ketamine are discussed, as well as pitfalls and caveats of intranasal drug use.
Export Options
About this article
Cite this article as:
Goldman D. Ran, Intranasal Drug Delivery for Children with Acute Illness, Current Drug Therapy 2006; 1 (1) . https://dx.doi.org/10.2174/157488506775268470
DOI https://dx.doi.org/10.2174/157488506775268470 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies
Current Pharmaceutical Design Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Anti-Cancer Agents in Medicinal Chemistry Role of COL4A1 in Basement-Membrane Integrity and Cerebral Small-Vessel Disease. The COL4A1 Stroke Syndrome
Current Medicinal Chemistry A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Renal Neoplasia in the Hyperparathyroidism-Jaw Tumor Syndrome
Current Molecular Medicine Polycystic Ovary Syndrome in Adolescents
Current Women`s Health Reviews Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?
Current Drug Targets Statistical Analysis, Optimization, and Prioritization of Virtual Screening Parameters for Zinc Enzymes Including the Anthrax Toxin Lethal Factor
Current Topics in Medicinal Chemistry Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology Novel Drugs for Neuroblastoma
Drug Design Reviews - Online (Discontinued) Structure-based Virtual Screening for the Identification of High-affinity Small Molecule Towards STAT3 for the Clinical Treatment of Osteosarcoma
Current Topics in Medicinal Chemistry New Chemotherapy and Immunotherapy for Tuberculosis
Current Respiratory Medicine Reviews Diabetes-induced Proteome Changes Throughout Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia
Recent Patents on Anti-Cancer Drug Discovery Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis
Current Pharmaceutical Design CAM Use in Pediatric Oncology
Current Pediatric Reviews Genetics of Serotonin Receptors and Depression: State of the Art
Current Drug Targets